Travere Therapeutics (TVTX) Tax Rate (2014 - 2026)

Travere Therapeutics has reported Tax Rate for 13 years, with the latest figure at 0.33% in Q1 2026.

• For the quarter ending Q1 2026, Tax Rate rose 42.0% year-over-year to 0.33%; the trailing twelve-month figure through Mar 2026 stood at 1.85% (down 186.0% YoY), and the FY2025 full-year result was 2.01%, down 197.0% from the prior year.
• Tax Rate for Q1 2026 stood at 0.33%, up from 4.37% in the prior quarter.
• The five-year high for Tax Rate was 0.33% in Q1 2026, with the low at 4.37% in Q4 2025.
• Historically, Tax Rate has averaged 0.29% across 5 years, with a median of 0.07% in 2022.
• Annual changes were most pronounced in 2022 — Tax Rate jumped 50 bps — and 2025, when it tumbled 449 bps.
• Travere Therapeutics' Tax Rate stood at 0.07% in 2022, then slipped by 4 bps to 0.08% in 2023, then soared by 255 bps to 0.12% in 2024, then sank by 3764 bps to 4.37% in 2025, then surged by 107 bps to 0.33% in 2026.
• The last three Tax Rate figures came in at 0.33% (Q1 2026), 4.37% (Q4 2025), and 0.03% (Q3 2025), per Business Quant data.